Tuesday, May 18, 2021
spot_img
HomeHealth CareGlobal Pain Therapeutics Market Is Expected To Reach US$ 85.4 Bn By...

Global Pain Therapeutics Market Is Expected To Reach US$ 85.4 Bn By 2025 | Acute Market Reports

spot_img

According to the latest market report published by Acute Market Reports “Pain Therapeutics  Market – Growth, Future Prospects and Competitive Analysis, 2017 – 2025” the global pain therapeutics  market was valued at US$ 53.2 Bn in 2016, and is expected to reach US$ 85.4 Bn by 2025, expanding at a CAGR of  5.3% from 2017 to 2025.

Pain therapeutics are used to relieve pain either by stopping the pain signals or by altering the brain interpretation to these signals. Pain therapeutics have the ability to reduce pain intensity but do not treat the cause of the pain. The global pain therapeutics market is anticipated to grow significantly over the forecast period due to growing incidence of chronic and pain inducing illnesses, strong presence of ideal pipeline molecules, growing number of surgeries and rising number of musculoskeletal disease, inflammatory disease, trauma and injuries to the internal organ.   

This study covered in-depth the study of geographical market segment. Market size and forecast is studied for regional and country level markets such as Europe (Germany, United Kingdom, and Rest of Europe), North America (Canada and United States), Latin America (Mexico, Brazil and Rest of Latin America), Asia Pacific (China, japan and Rest of APAC), Middle East and Africa (GCC and Rest of Middle East and Africa).   

Along with the statistical information, qualitative information is also included in report for further understanding of current market position and future market scenario. To provide information related to ongoing trend of market, in-depth information related to pain therapeutics market drivers, opportunities and challenges are also included in this report. In addition, competitive environment, information related to the market positioning of key manufacturer and attractive investment proposition are also covered in this report.

Browse the full report Pain Therapeutics Market – Growth, Future Prospects and Competitive Analysis, 2017 – 2025 at https://www.acutemarketreports.com/report/pain-therapeutics-market

Based on drug classes, the global pain therapeutics market is segmented as follows:

  • Acetaminophen and Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  • Opioids   
  • Anesthetics
  • Anticonvulsants
  • Corticosteroids 
  • Antidepressants
  • Other

Based on the types of pain, the global pain therapeutics market is segmented as follows:  

  • Nociceptive Pain
    • Somatic Pain
    • Visceral Pain
    • Cutaneous Pain
  • Neuropathic Pain
  • Psychogenic Pain  

For the purpose of this study, the global pain therapeutics market is categorized into the following geographical regions:

  • North America
    • United States
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Rest of Middle East and Africa

Market Insights

Global pain therapeutics market is segmented on the basis of major drug class types such as acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs), opioids, anesthetics, anticonvulsants, corticosteroids, antidepressants and others. Due to their proven effectiveness, the demand for acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) is highest in market. However, stringent regulatory guidelines for the use of opioid drugs is negatively impacting the growth of opioids market.

For this study, pain therapeutics market is categorized on the basis of major pain type such as nociceptive pain (somatic pain, visceral pain and cutaneous pain), neuropathic pain and psychogenic pain. At present, the demand for nociceptive pain therapeutics is the highest in market, due to its widespread incidence. Pain therapeutics for neuropathic pain is anticipated to show the fastest market growth over the forecast period due to higher number of unmet needs, increasing number of disease such as diabetes, neuralgia, cancer etc. Furthermore, presence of ideal pipeline drugs such as TV-45070, PF-04383119, AGN-203818, GRO-12, REGN-475, KRN-5500, xpf-002 etc. would assist the growth of neuropathic pain therapeutics market over the forecast period.  

Request Sample Copy Here

At present, North America is the largest regional market for pain therapeutics with the United States accounting for the highest market share due to higher cost of therapeutics, massive R&D activities for drug discovery, higher number of target population, high healthcare awareness and increase in number of pain management centers. However, Asia Pacific is anticipated to grow significantly over the forecast period due to large pool of target population, developing economic condition and growing healthcare expenditure.

Market Competition Assessment:

Pain therapeutics market is highly competitive and involves large number of manufacturers. However, market is dominated by few players such as Abbott Laboratories, AstraZeneca Plc., Biogen Idec Inc., Bristol-Myers Squibb and Company, Depomed Inc., Eli Lily and Company, GlaxoSmithKline PLC., Johnson & Johnson Services Inc., Mallinckrodt Plc., Merck & Co. Inc., Novartis AG, Pfizer Inc., Purdue Pharma L.P., Sanofi S.A. and others.

Key Market Movements:

  • Factors such as increase in demand for pain therapeutics, growing number of surgeries, rising number of chronic disease, increasing number accidents related injuries and trauma, strong presence of pipeline drugs would drive pain therapeutics market growth during forecast period
  • Significant unmet needs for treatment of neuropathic pain, key players in the market are focusing on innovation and advancement in pain therapeutics would further influence the growth of pain therapeutics market

Table Of Contents

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Pain Therapeutics Market Portraiture
2.1.1. Global Pain Therapeutics Market, by Drug Class, 2016
2.1.2. Global Pain Therapeutics Market, by Pain Type, 2016
2.1.3. Global Pain Therapeutics Market, by Geography, 2016

Chapter 3. Pain Therapeutics: Market Dynamics and Outlook
3.1. Market Definition and Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2016
3.6. Competitive Landscape
3.6.1. Competitive Landscape, by Key Players, 2016

Chapter 4. Pipeline Analysis of Pain Therapeutics
4.1. Overview
4.2. Projected Sales of Phase III Pain Therapeutics Estimated Till 2025 (US$ Bn)
4.3. Tabular Representation of Phase II and I Pain Therapeutics

Chapter 5. Global Pain Therapeutics Market, by Drug Class, 2015 – 2025 (US$ Bn)
5.1. Overview
5.1.1. Attractive Investment Proposition, by Drug Class, 2016
5.2. Acetaminophen and Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
5.3. Opioids
5.4. Anesthetics
5.5. Anticonvulsants
5.6. Corticosteroids
5.7. Antidepressants
5.8. Other

Chapter 6. Global Pain Therapeutics Market, by Pain Type, 2015 – 2025 (US$ Bn)
6.1. Overview
6.2. Nociceptive Pain
6.2.1. Somatic Pain
6.2.2. Visceral Pain
6.2.3. Cutaneous Pain
6.3. Neuropathic Pain
6.4. Psychogenic Pain

Chapter 7. Global Pain Therapeutics Market, by Geography, 2015 – 2025
7.1. Overview
7.2. North America Pain Therapeutics Market Analysis, 2015 – 2025
7.2.1. North America Pain Therapeutics Market, by Drug Class, 2015 – 2025 (US$ Bn)
7.2.2. North America Pain Therapeutics Market, by Pain Type, 2015 – 2025 (US$ Bn)
7.2.3. North America Pain Therapeutics Market, by Country, 2015 – 2025 (US$ Bn)
7.2.3.1. U.S.
7.2.3.2. Canada
7.3. Europe Pain Therapeutics Market Analysis, 2015 – 2025
7.3.1. Europe Pain Therapeutics Market, by Drug Class, 2015 – 2025 (US$ Bn)
7.3.2. Europe Pain Therapeutics Market, by Pain Type, 2015 – 2025 (US$ Bn)
7.3.3. Europe Pain Therapeutics Market, by Country, 2015 – 2025 (US$ Bn)
7.3.3.1. U.K.
7.3.3.2. Germany
7.3.3.3. Rest of Europe
7.4. Asia Pacific Pain Therapeutics Market Analysis , 2015 – 2025
7.4.1. Asia Pacific Pain Therapeutics Market, by Drug Class, 2015 – 2025 (US$ Bn)
7.4.2. Asia Pacific Pain Therapeutics Market, by Pain Type, 2015 – 2025 (US$ Bn)
7.4.3. Asia Pacific Pain Therapeutics Market, by Country, 2015 – 2025 (US$ Bn)
7.4.3.1. China
7.4.3.2. Japan
7.4.3.3. Rest of APAC
7.5. Latin America Pain Therapeutics Market Analysis , 2015 – 2025
7.5.1. Latin America Pain Therapeutics Market, by Drug Class, 2015 – 2025 (US$ Bn)
7.5.2. Latin America Pain Therapeutics Market, by Pain Type, 2015 – 2025 (US$ Bn)
7.5.3. Latin America Pain Therapeutics Market, by Country, 2015 – 2025 (US$ Bn)
7.5.3.1. Brazil
7.5.3.2. Mexico
7.5.3.3. Rest of Latin America
7.6. Middle East & Africa (MEA) Pain Therapeutics Market Analysis, 2015 – 2025
7.6.1. MEA Pain Therapeutics Market, by Drug Class, 2015 – 2025 (US$ Bn)
7.6.2. MEA Pain Therapeutics Market, by Pain Type, 2015 – 2025 (US$ Bn)
7.6.3. MEA Pain Therapeutics Market, by Region, 2015 – 2025 (US$ Bn)
7.6.3.1. GCC
7.6.3.2. Rest of MEA

Chapter 8. Company Profiles
8.1. Abbott Laboratories
8.1.1. Business Description
8.1.2. Financial Information (Subject to data availability)
8.1.3. Product Portfolio
8.1.4. Key Developments
8.2. AstraZeneca plc.
8.3. Biogen Idec Inc.
8.4. Bristol-Myers Squibb and Company
8.5. Depomed Inc.
8.6. Eli Lily and Company
8.7. GlaxoSmithKline PLC.
8.8. Johnson & Johnson Services Inc.
8.9. Mallinckrodt plc.
8.10. Merck & Co. Inc.
8.11. Novartis AG
8.12. Pfizer Inc.
8.13. Purdue Pharma L.P.
8.14. Sanofi S.A.
8.15. Other Notable Players

About Us

Acute Market Reports is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives.

Contact

Acute Market Reports
Address: 90 Church St, FL 1 #3514,
New York, NY 10008 United States
Toll Free(US/CANADA): +1-855-455-8662
E-mail: sales@acutemarketreports.com

Most Popular